A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies

• المؤلفون الرئيسيون: Ho, Jingshan, Heong, Valerie, Yong, Wei Peng, Soo, Ross, Chee, Cheng Ean, Wong, Andrea, Sundar, Raghav, Thian, Yee Liang, Gopinathan, Anil, Pang, Mei Yan, Koe, Priscillia, Jeraj, Santhiay Nathan, Soe, Phyu Pyar, Soe, Mu Yar, Tang, Tiffany, Ng, Matthew CH, Tai, David WM, Tan, Tira JY, Xu, Hongmei, Chang, Hua, Landesman, Yosef, Shah, Jatin, Shacham, Sharon, Lee, Soo Chin, Tan, Daniel SW, Goh, Boon Cher, Tan, David SP
• مؤلفون آخرون: DIAGNOSTIC RADIOLOGY
• التنسيق: مقال
• اللغة: English
• منشور في: SAGE PUBLICATIONS LTD 2022
• الموضوعات: Science & Technology; Life Sciences & Biomedicine; Oncology; advanced malignancies; Asian; clinical trial; phase 1; selinexor; ANTITUMOR-ACTIVITY; DEXAMETHASONE; 1ST-IN-CLASS; CONSENSUS; LYMPHOMA; CRITERIA
• الوصول للمادة أونلاين: https://scholarbank.nus.edu.sg/handle/10635/226297

10.1177/17588359221087555